EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study

Chuanpei Cao, Fan Tang, Zhihua Zhu, Feng Wang, Jinfeng Li

PeerJ · 17.06.2026 · 14 · e21449

DOI: 10.7717/peerj.21449 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift PeerJ, online erschienen am 17.06.2026. Verfasst von Chuanpei Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jiujiang College Affiliated Hospital, Jiujiang, Jiangxi, China. Hauptthemen laut MEDLINE: Ferritins, Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) stage plays a major role in treatment decisions and prognosis. This study investigates whether Serum Ferritin can improve CRC staging and compares its performance to standard markers like carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA).

Methods

We analyzed data from 419 CRC patients at Jiujiang College Affiliated Hospital, dividing them into early-stage (I–II, 245 patients) and late-stage (III–IV, 174 patients) groups. Logistic regression and receiver operating characteristic (ROC) curves were used to assess the usefulness of serum ferritin compared with traditional markers.

Results

Serum Ferritin was significantly higher in late-stage CRC ( P < 0.001). ROC analysis showed Serum Ferritin had a numerically higher area under the curve (AUC) (0.795) compared to CA 19-9 (0.745) and CEA (0.744) at distinguishing between early and advanced stages. The combined model yielded an AUC of 0.890.

Conclusion

Serum Ferritin could be a useful addition to CRC staging, showing a numerically higher AUC than current markers. Adding it to clinical practice may help refine stage assessment and guide treatment decisions. This study supports its potential as a supplementary tool for stage assessment in CRC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerritinsColorectal NeoplasmsBiomarkers, TumorHumansRetrospective StudiesFemaleNeoplasm StagingCarcinoembryonic AntigenMiddle AgedAgedMaleCA-19-9 AntigenROC Curve

Stichwörter der Autor:innen

BiomarkersCancer stagingColorectal cancerSerum ferritinStaging accuracy

Substanzen

FerritinsBiomarkers, TumorCarcinoembryonic AntigenCA-19-9 Antigen

Autor:innen und Institutionen

  • Jiujiang College Affiliated Hospital, Jiujiang, Jiangxi, China.
  • Jiangxi Dermatology Hospital, Nanchang, Jiangxi, China.
  • Department of Hematology, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang NO.1 People's Hospital, Jiujiang, Jiangxi, China.

Zitieren

APA

Cao, C., Tang, F., Zhu, Z., Wang, F., & Li, J. (2026). Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study. PeerJ, 14, e21449. https://doi.org/10.7717/peerj.21449

Vancouver

Cao C, Tang F, Zhu Z, Wang F, Li J. Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study. PeerJ. 2026;14:e21449. doi:10.7717/peerj.21449

BibTeX
@article{Cao2026,
  author = {Cao, Chuanpei and Tang, Fan and Zhu, Zhihua and Wang, Feng and Li, Jinfeng},
  title = {Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21449},
  doi = {10.7717/peerj.21449}
}
Kostenlos starten →